faculty photo

Alexis Ogdie-Beatty, MD, MSCE

Associate Professor of Medicine (Rheumatology) at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
3400 Spruce Street
5 White Building
Hospital of the University of Pennsylvania
Philadelphia, PA 19104-4283
Office: 215-662-2454
Fax: 215-662-4500
University of Minnesota, 2002.
Georgetown University School of Medicine, 2006.
University of Pennsylvania, 2012.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Webster DE, Haberman RH, Chada LMP, Tummalacherla M, Tediarjo A, Yadav V, Neto EC, MacDuffie W, DePhillips M, Sieg E, Catron S, Grant C, Francis W, Nguyen M, Yussuff M, Castillo RL, Yan D, Neimann AL, Reddy SM, Ogdie A, Kolivras A, Kellen MR, Mangravite LM, Sieberts SK, Omberg L, Merola JF, Scher JU.: Clinical validation of digital assessment tools and machine learning models for remote measurement of psoriasis and psoriatic arthritis: a proof-of-concept study. J Rheumatol Jun 2024.

Gossec L, Orbai AM, de Wit M, Coates LC, Ogdie A, Ink B, Coarse J, Lambert J, Taieb V, Gladman DD.: Effect of Bimekizumab on Patient-Reported Disease Impact in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies. Rheumatology (Oxford) May 2024.

Mease P, Reed G, Ogdie A, Pappas DA, Kremer JM.: Prevalence of Fibromyalgia and Widespread Pain in Psoriatic Arthritis: Association with Disease Severity Assessment in a Large US Registry. Arthritis Care Res (Hoboken) May 2024.

Nowell WB, Gavigan K, Garza K, O'Beirne R, Safford M, George M, Ogdie A, Walsh JA, Danila MI, Venkatachalam S, Stradford L, Rivera E, Curtis JR.: Which education topics and smartphone app functions are prioritized by U.S. rheumatology patients? A mixed-methods study. J Rheumatol May 2024.

Strand V, Gossec L, Coates LC, Ogdie A, Choi J, Becker B, Zhuo J, Lehman T, Nowak M, Elegbe A, Mease PJ, Deodhar A.: Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial. Arthritis Care Res (Hoboken) Mar 2024.

Hwang MC, Bell C, Farran Y, Ogdie A, Green C, Reveille J.: Reliability and validity of the PROMIS-29 health profile in Ankylosing Spondylitis patients: A cross-sectional study. Medicine (Baltimore) 103: e37251, Mar 2024.

Song WB, Garshick MS, Barbieri JS, Shin DB, Báez S, Papadopoulos M, Neopaney A, Fitzsimmons R, Kalb RE, Mease PJ, Craig ET, Koplin J, Takeshita J, Chiesa Fuxench ZC, Armstrong AW, Mehta NN, Beidas RS, Ogdie AR, Gelfand JM.: A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study. J Invest Dermatol Epub, Jan 2024.

Gossec L, Orbai AM, Coates LC, Gladman DD, Ogdie A, Pelligra CG, Ciaravino V, Ink B, Taieb V, Lambert J, de Wit M.: Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD Open 10: e003548, Jan 2024.

Mease PJ, Young P, Fallon L, Mundayat R, Dina O, Blachley T, Middaugh N, Ogdie A.: Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. Rheumatol Ther Epub, Jan 2024.

Mease PJ, Gottlieb AB, Ogdie A, McInnes IB, Chakravarty SD, Rampakakis E, Kollmeier A, Xu XL, Shawi M, Lavie F, Kishimoto M, Rahman P.: Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment. Clin Rheumatol 43(1): 241-249, Jan 2024.

back to top
Last updated: 06/28/2024
The Trustees of the University of Pennsylvania